Chronic wounds, a major clinical challenge, still need to develop new methods based on efficient technologies to improve treatment results. Stem cells, particularly mesenchymal stem cells (MSC), as an advanced approach in skin regenerative medicine, brought new hopes. The multifaceted effects of MSCs, including paracrine signaling, trophic factor secretion, and modulation of the wound microenvironment, orchestrate a cascade of regenerative, plays a critical role in tissue repair. Preclinical investigations have revealed the regenerative capacity of MSCs in accelerating wound closure, promoting angiogenesis, and fostering a pro-healing environment in chronic wound models. Clinical trials have also confirmed these findings and show the efficacy of MSC treatment in accelerating wound healing and improving the quality of healed tissue in patients with chronic wounds. Despite the therapeutic progress, key issues, such as optimal cell sourcing, cell dosage, delivery modalities, and long-term safety profiles, there are a number of unresolved issues which need to be dealt with. This review aims to provide a comprehensive overview of current state of stem cell research in wound healing, and offers a new new hope for effective and innovative treatments in regenerative medicine.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.22074/cellj.2024.2034492.1613 | DOI Listing |
ACS Appl Bio Mater
March 2025
Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow 226025, India.
Multidrug resistance (MDR) infectious wounds are a major concern due to drug resistance, leading to increased patient morbidity. Lichenysin (LCN), a lipopeptide and biosurfactant obtained from certain strains of , has demonstrated an excellent antimicrobial property. The present study focuses on the fabrication and comprehensive evaluation of LCN-incorporated poly(vinyl alcohol) (PVA)/polycaprolactone (PCL)-based nanofiber scaffolds using an electrospinning technique as a potential wound healing biomaterial for the treatment of MDR infectious wounds in diabetic rats.
View Article and Find Full Text PDFFitoterapia
March 2025
Institute for Medicinal Plants Research "Dr. Josif Pančić", 11000 Belgrade, Serbia.
This study aimed to perform chemical characterization of black raspberry seed oil (Rubus occidentalis L., Rosaceae) from Serbia in terms of fatty acids and tocols composition, total carotenoid content, as well as to investigate its antioxidant/antimicrobial activities and in vitro wound-healing potential. GC/MS analysis revealed that linoleic (39.
View Article and Find Full Text PDFInt J Biol Macromol
March 2025
Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
The current research emphasis is on the development of wound dressings that can inhibit bacterial infections and facilitate the treatment of complex wound healing processes. In this study, nanofibrous mats of polyvinyl alcohol/chitosan/ZIF-67(PVA/Cs/ZIF-67) were prepared using an electrospinning technique, to investigate their antibacterial and regenerative properties in a rat model of full-thickness skin wounds. ZIF-67 nanoparticles, with an average size of approximately 373.
View Article and Find Full Text PDFInt J Biol Macromol
March 2025
Department of Orthopedics, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, China. Electronic address:
Electrospun pectin nanofibers have emerged as a transformative advancement in biomaterials, offering remarkable potential across diverse biomedical and industrial applications. This review explores the synthesis, optimization, and versatile applications of electrospun pectin nanofibers, highlighting their unique properties, including biocompatibility, biodegradability, and adaptability for functionalization. Pectin's structural diversity, coupled with its ability to form hydrogels and interact with biological systems, makes it a promising candidate for wound healing, drug delivery, tissue engineering, and smart packaging.
View Article and Find Full Text PDFJ Pharmacol Exp Ther
February 2025
Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland.
Pulmonary fibrosis encompasses different chronic interstitial lung diseases, and the predominant form, idiopathic pulmonary fibrosis, remains to have a poor prognosis despite 2 approved therapies. Although the exact pathobiological mechanisms are still incompletely understood, epithelial injury and aberrant wound healing responses contribute to the gradual change in lung architecture and functional impairment. Lysophosphatidic acid (LPA)-induced lysophosphatidic receptor 1 (LPA1) signaling was proposed to be a driver of lung fibrosis, and LPA1 antagonists have shown promising antifibrotic profiles in early clinical development.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!